Latest Breaking News On - First antibody fragment based dual - Page 1 : vimarsana.com

Proceeds Support Advancement of the M-gager Platform Technology and Lead Product Candidate CDR404, a First Antibody Fragment-based Dual MAGE-A4 T Cell Engager, and Other Discovery ProgramsZÜRICH, Switzerland

Christian leisnerKostenloser wertpapierhandelM gager platform technologyCompany board of directorsBoehringer ingelheimCompanym gagerProceeds support advancementLead product candidateFirst antibody fragment based dualCell engagerJeito capitalDaniel marksClaudio nessiManaging directorOmega fundsChief executive officer